You bet it is - it's called the Adapt process.
Smothered in patents.
It leaves the tissue strengthened by crosslinking (from the use of glutaraldehyde) but at the end of the process none of the glut is left in the tissue. (It is this molecule that later causes calcification in all the other tissue patches because it is still present within the tissue).
Adapt is unique and patented.
Ann: Update on the CardioCel 3D Product Launch, page-88
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $17.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |